Instylla announces enrollment of initial patient in the prospective multicenter “HALT” Study
Patients with upper GI bleeds, kidney, liver, or spleen end organ bleeds, spontaneous hematomas, or other peripheral arterial bleeds such as pelvic hemorrhage may be considered suitable for this study.